On December 20, 2021, the Company completed a purchase of 13 acres of land in the Verona Technology Park in Verona, Wisconsin, which is being developed into an approximately 160,000 square foot drug manufacturing facility and an approximately 140,000 square foot laboratory and office facility which will support the Company’s process development and analytical activities.
−Removed: Additionally, the Company entered into a lease agreement for a new 144,000 square foot laboratory and office facility in San Diego, California to support discovery activities, which it currently anticipates to be available starting around April 2023.
+Added: Additionally, the Company entered into a lease agreement for a new 144,000 square foot laboratory and office facility in San Diego, California to support discovery activities;
+Added: the rent commencement date was April 19, 2023.
The following table summarizes the Company’s leased facilities as of September 30, 2023.
−Removed: Space (sq.ft) Monthly
−Removed: Expenses Primary Use Lease
−Removed: Expiration Lease
+Added: Approximate Square Footage Primary Use Lease
+Added: Expiration Remaining Lease
Pasadena, California 49,000 Corporate Headquarters April 2027 3.6
Madison, Wisconsin 115,000 Research Facility September 2031 7.9
−Removed: San Diego, California 21,000 $ 61,821 Research Facility January 2023 2.3
−Removed: San Diego, California 10,000 $ 33,379 Office Space March 2023 1.2
+Added: San Diego, California 144,000 Research and Office Facility April 2038 14.6
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.